1. A Cancer Chemo-Prevention Compromise
Now some of the ethical challenges in chemo-prevention research will be analyzed, and the agents inscribing the procedures for phase III chemo-prevention trials and Institutional Review Board (IRB) members that review these practices. Phase III trials are designed to assess the effectiveness of an experimental agent in comparison to the available standard of care regimen (Lancet 1). ...
- Word Count: 1354
- Approx Pages: 5
- Has Bibliography
- Grade Level: Graduate